These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25377273)

  • 61. Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management.
    Smets F; Sokal EM
    Pediatr Transplant; 2002 Aug; 6(4):280-7. PubMed ID: 12234267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Post-transplant lymphoproliferative disorder in children: incidence, prognosis, and treatment options.
    Faye A; Vilmer E
    Paediatr Drugs; 2005; 7(1):55-65. PubMed ID: 15777111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Post-transplant lymphoproliferative disorder.
    Kalinova L; Indrakova J; Bachleda P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):251-7. PubMed ID: 20208963
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Posttransplant lymphoproliferative disorder following pancreas transplantation.
    Issa N; Amer H; Dean PG; Kremers WK; Kudva YC; Rostambeigi N; Cosio FG; Larson TS; Habermann TM; Stegall MD; Griffin MD
    Am J Transplant; 2009 Aug; 9(8):1894-902. PubMed ID: 19519812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
    Francis A; Johnson DW; Teixeira-Pinto A; Craig JC; Wong G
    Nephrol Dial Transplant; 2018 May; 33(5):881-889. PubMed ID: 29342279
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying the patient at risk for post-transplant lymphoproliferative disorder.
    Cockfield SM
    Transpl Infect Dis; 2001 Jun; 3(2):70-8. PubMed ID: 11395972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Post-transplantation lymphoproliferative disorder in childhood].
    Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
    Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():31-3, 35-6. PubMed ID: 12091638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
    Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
    Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of post-transplant lymphoproliferative disease with rituximab].
    Jiang YJ; Wang X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):852-6. PubMed ID: 24989308
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-transplant lymphoproliferative disorders.
    Dharnidharka VR; Webster AC; Martinez OM; Preiksaitis JK; Leblond V; Choquet S
    Nat Rev Dis Primers; 2016 Jan; 2():15088. PubMed ID: 27189056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Post-transplant lymphoproliferative disorder after paediatric liver transplantation.
    Liu Y; Sun LY; Zhu ZJ; Wei L; Qu W; Wang L; Yuan LL; Zeng ZG
    Int J Clin Pract; 2021 Apr; 75(4):e13843. PubMed ID: 33222369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Post-transplant lymphoproliferative disease in liver transplant recipients.
    Rubio-Manzanares Dorado M; Álamo Martínez JM; Bernal Bellido C; Marín Gómez LM; Suárez Artacho G; Cepeda Franco C; Wang J; Gómez Bravo MÁ; Padillo FJ
    Rev Esp Enferm Dig; 2017 Jun; 109(6):406-413. PubMed ID: 28508661
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A multicenter survey on post-transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatment?
    Weisert M; Harake D; Hede S; Russell M; Alejos J; Menteer J
    Pediatr Transplant; 2020 Aug; 24(5):e13730. PubMed ID: 32416037
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis and treatment of adult patients with PTLD at different sites after liver transplantation: A three-case report and literature review.
    Zhang Y; Lv Y; Wang B; Liu C; Wu R; Zhang X; Li Y; Tian M
    Transpl Immunol; 2023 Oct; 80():101881. PubMed ID: 37392897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
    Martínez-Calle N; Alfonso A; Rifón J; Herrero I; Errasti P; Rábago G; Merino J; Panizo Á; Pardo J; Prósper F; García-Muñoz R; Lecumberri R; Panizo C
    Eur J Haematol; 2017 Jan; 98(1):38-43. PubMed ID: 27232286
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience.
    Nakanishi C; Kawagishi N; Sekiguchi S; Akamatsu Y; Sato K; Miyagi S; Takeda I; Fukushima D; Kobayashi Y; Ishida K; Niizuma H; Tsuchiya S; Wada M; Nio M; Satomi S
    Surg Today; 2012 Aug; 42(8):741-51. PubMed ID: 22278621
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
    Steiner R; Kridel R; Giostra E; McKee T; Achermann R; Mueller N; Manuel O; Dickenmann M; Schuurmans MM; de Leval L; Fehr T; Tinguely M; Binet I; Cogliatti S; Haralamvieva E; Koller M; The Swiss Transplant Cohort Study Stcs ; Dietrich PY
    Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Posttransplantation lymphoproliferative disease: proposed imaging classification.
    Camacho JC; Moreno CC; Harri PA; Aguirre DA; Torres WE; Mittal PK
    Radiographics; 2014; 34(7):2025-38. PubMed ID: 25384299
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.
    Végso G; Hajdu M; Sebestyén A
    Pathol Oncol Res; 2011 Sep; 17(3):443-54. PubMed ID: 21193979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.